For more information, contact:
Jeff Butler
Public Relations Account Executive
Morton Vardeman & Carlson
770-536-8921
jeff@vardeman.com
Lohmann Animal Health Begins Construction on Biological Production Center
Expansion will provide greater vaccine production capacity
WINSLOW, Maine (Sept. 15, 2009) — Lohmann Animal Health is continuing a major expansion project at its Winslow, Maine headquarters.
Lohmann Animal Health has begun building its biological production center, which is expected to be completed early next summer. This is part of a three-year $8.8 million expansion project.
The 12,500-square foot building will expand production capabilities for bacterial vaccines by at least five times current capacity. The new space also allows for some automation in the production process.
"The multi-million dollar expansion will provide greater production capacity to permit meeting increased demands for Lohmann vaccines,” Lohmann Animal Health CEO Dave Zacek said. "It will improve traffic control, expand offices for production management, and add meeting and training rooms.”
Next to be completed in the expansion project is a larger, more efficient animal testing facility that will be completed this fall. The final phase of the project will be a new Research & Development Center, which will provide laboratories, scientist offices, BL 2 level isolation and more space for challenge studies.
Based in Winslow, Maine, LAH is a member of the PHW Group, which comprises 40 companies that produce poultry health products for the global market. For more information, contact LAH at (800) 655-1342 or visit the company's website at www.lahinternational.com.
###
|
